Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Always base your calculations on your actual vial concentration, never on information from a different product
Semaglutide selectively activates the GLP-1 receptor, producing: Glucose-dependent insulin secretion : Reduces hypoglycemia risk compared to non-incretin agents Glucagon suppression : Reduces hepatic glucose output in the hyperglycemic state Gastric emptying delay : Contributes to postprandial glucose control and satiety Central appetite regulation : Acts on GLP-1 receptors in the hypothalamus and brainstem to reduce hunger and alter food preferences The simplicity of semaglutide's single-receptor mechanism is both a limitation (no energy expenditure enhancement from glucagon) and a strength (thoroughly understood pharmacology, predictable effects, extensive safety characterization)
Batch-Specific Documentation Every vial is labelled with a unique batch number tied to its specific production batch
MRP: 3300.00 Price: 3199.00 You Save: 101 (3% off) Rybelsus 7mg Tablet contains Semaglutide, a medication used primarily to manage type 2 diabetes mellitus
US$ 23.30
US$ 29.11
US$ 21.93
